Annovis Bio is down -3.8%, or -26c to $6.51.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio’s Alzheimer’s Drug Buntanetap Shows Promise
- Annovis’ buntanetap found safe, effective in high-risk Alzheimer’s patients
- Annovis Bio’s Buntanetap Found Safe and Effective in High-Risk Alzheimer’s Patients
- Largest borrow rate increases among liquid names
- Annovis Bio Schedules Insightful Investor Webcast for June